Helio Genomics
Share
Helio Genomics (formerly Helio Health) is an AI-driven healthcare company focused on developing and commercializing early cancer detection tests from a simple blood draw. Helio Genomics is a multinational business with collaborations in both the United States and China, including leading scientists, physicians, research institutions, and business leaders from both countries. Helio Genomics strives
12/21/2022
Are you up to date with your early cancer detection guidelines? Studies have shown that Helio’s criteria to select and investigate certain genes is more robust and precise, suggesting HelioLiver’s markers are more biologically relevant than competitor tests that utilize other genes.
12/16/2022
One of our biggest accomplishments this year has been our ENCORE publication in Hepatology Communications. Read the full journal article here: https://bit.ly/3uYuvLO
12/06/2022
Our CEO, Justin Chen Li, was interviewed in Park City, Utah at . Justin speaks about the origin of and how to use artificial intelligence to effectively detect cancer. Watch the video to learn more!
Saving Lives with AI - Early Cancer Detection We recently took part in the Internet Marketing Association’s IMPACT 22 conference, which took place in Park City, Utah. Our CEO, Justin Chen Li, was intervi...
11/11/2022
HelioLiver offers a reliable and accessible approach to testing as a simple blood draw and has been validated in clinical studies with promising results. Ultrasound is the standard of care for liver surveillance, yet is widely perceived by physicians as inadequate, owing both to performance factors and barriers to patients receiving the ultrasound.
Click here to claim your Sponsored Listing.
Category
Website
Address
9950 Research Drive
Irvine, CA
92618
